- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
InspireMD Inc (NSPR)
The InspireMD share price today is 0.900, view NASDAQ NSPR stock exchange data. Track the latest InspireMD share price with real-time updates on NSPR stock performance including market cap, day range, 52-week range and dividend yield. Access NSPR charts, earnings dates and analyst estimates to support your investment decisions.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.850
0.900
52 wk Range
0.630
2.565
NSPR is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8500.900
52 wk Range
0.6302.565
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NSPR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
3.333
Upside
+270.37%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
Form 8K InspireMD Inc For: 17 August- Investing.com
- Form 8K InspireMD Inc For: 17 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.333
(+270.37% Upside)
InspireMD Inc Earnings Call Summary for Q2/2026
- InspireMD posted Q2 revenue of $1.77M, missing estimates by 30% due to voluntary recall of C-Guard Prime 135 carotid stent system in late April.
- Company reported adjusted loss of $0.17/share, beating expectations by $0.01, but shares fell 6% as recall drove gross margin to negative 43.7%.
- International revenue rose 21% YoY to $2.1M, offsetting U.S. sales collapse; company announced 20% workforce reduction to save $9M annually.
- Management expects FDA decisions on C-Guard Prime 80 and original CGuard platform in Q4 2026, with redesigned Prime 135 returning in H1 2027.
- Cash position declined to $30.4M from $54.2M at year-end 2025, increasing pressure to control burn rate ahead of anticipated U.S. product relaunch.
Last Updated: 17-08-2026, 06:46 pm
Read Full TranscriptEarnings
Latest Release
17-08-2026
EPS / Forecast
-0.17 / -0.18
Revenue / Forecast
1.77M / 2.54M
Compare NSPR to Peers and Sector
Metrics to compare | NSPR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNSPRPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.8x | −1.5x | −0.3x | |
PEG Ratio | −0.04 | −0.10 | 0.00 | |
Price/Book | 1.3x | 2.6x | 2.6x | |
Price / LTM Sales | 3.9x | 2.6x | 3.1x | |
Upside (Analyst Target) | 233.3% | 12.4% | 47.6% | |
Fair Value Upside | Unlock | 19.9% | 5.6% | Unlock |
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the InspireMD (NSPR) Share Price Today?
The InspireMD share price today is 0.900.
What is the current InspireMD (NSPR) share price and day range?
As of 22-08-2026, the InspireMD share price is 0.900, with a previous close of 0.900. The share price has ranged from 0.850 to 0.900 today, while the 52-week range spans from 0.630 to 2.565.
What Is the InspireMD Market Cap?
As of today, InspireMD market cap is 42.150M.
What Is the InspireMD (NSPR) Share Price Target?
The average 12-month share price target for InspireMD is 3.333, with a high estimate of 4 and a low estimate of 3. 3 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +270.37% Upside potential.
What Is InspireMD's Earnings Per Share (TTM)?
The InspireMD EPS (TTM) is -0.646.
When Is the Next InspireMD Earnings Date?
InspireMD will release its next earnings report on 10-11-2026.
From a Technical Analysis Perspective, Is NSPR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does InspireMD Trade On?
InspireMD is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for InspireMD?
The stock symbol for InspireMD is "NSPR."
How Many Times Has InspireMD Stock Split?
InspireMD has split 6 times.
How Many Employees Does InspireMD Have?
InspireMD has 127 employees.
What Is the NSPR After Hours Price?
NSPR's last after hours stock price is 0.898, the stock has changed by -0.002, or -0.200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.